Robotic-Assisted Radical Cystectomy Safe, Feasible for Octogenarians
The benefits of robotic surgery may have a more pronounced effect in octogenarians, according to investigators.
Genitourinary Cancer
Nadofaragene Firadenovec Shows Longer-Term Efficacy in BCG-Unresponsive NMIBC
Study results support an attempt at bladder preservation in patients with BCG-unresponsive nonmuscle-invasive bladder cancer.
Study Reveals Causes of Premature Death in Testicular Cancer Survivors
Certain treatments were associated with an increased risk of death unrelated to testicular cancer.
Nursing Cases: Nurse Advocates for Patient’s Participation in Shared Decision Making
A nurse coordinated a meeting to ensure the patient’s preferences were shared with his multidisciplinary care team.
Pembrolizumab Monotherapy for BCG-Unresponsive, Non–Muscle-Invasive Bladder Cancer
Patients with BCG-unresponsive, non–muscle-invasive bladder cancer who received pembrolizumab had a complete response rate of 41%.
ctDNA Testing May Guide Precision Treatment in Urothelial Carcinoma
Patients who have ctDNA-positive urothelial carcinoma were found to be at higher risk for disease recurrence than those with a ctDNA-negative status.
No Benefit With Adjuvant Atezolizumab in Muscle-Invasive Urothelial Carcinoma
The aim of the trial was to determine if adjuvant atezolizumab improved disease-free survival.
Study: Routine Surveillance Crucial After Radical Cystectomy
Low adherence to post-radical cystectomy surveillance guidelines may increase patients’ mortality risk, study findings suggest.
Prophylactic Ureteral Stenting Linked to Upper Tract Urothelial Carcinoma
In current urological practice, clinicians decide whether to place a ureteral stent or nephrostomy, but evidence-based treatment guidance is needed.
Trodelvy Gets Accelerated Approval for Urothelial Cancer
The accelerated approval was based on data from the multicenter, open-label, phase 2 TROPHY study.
- Loading...
Loading...
Next post in Genitourinary Cancer
Loading... 
Loading...